Zynex Inc. (ZYXI)

[dokkay]

The company's IF devices are great units, probably the most effective device they have. As it was indicated in the release, they are discussing future changes to coverage on several product types with Anthem that the management hopes will be helpful to the company, Anthem patients and prescribing doctors in the future. The company does not see any other problems on the horizon, other than the daily slew of claims being denied by insurance companies and their efforts and predominantly success in winning all these appeals every day. The Anthem issue only relates to certain devices out of many that the company carries and has more to do with a dispute over the quality of clinical studies published in the past than anything else. Ofcourse, they will continue to talk with Anthem about these issues.